B Moon Kim Selected Research

4- amino- 6- bromo- 1- (3,4- dihydroxy- 5- (hydroxymethyl)tetrahydrofuran- 2- yl)- 1H- pyrrolo(2,3- d)pyrimidine- 5- carboxamide

6/2011

Ibulocydine is a novel prodrug Cdk inhibitor that effectively induces apoptosis in hepatocellular carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

B Moon Kim Research Topics

Disease

5	Neoplasms (Cancer) 04/2021 - 06/2011
3	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 06/2011
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Cardiotoxicity 01/2017
1	Inflammation (Inflammations) 01/2008

Drug/Important Bio-Agent (IBA)

3	(5- (4- amino- 6- bromo- 5- carbamoyl- 1H- pyrrolo(2,3- d)pyrimidin- 1- yl)- 3,4- dihydroxytetrahydrofuran- 2- yl)methyl isobutyrateIBA 01/2017 - 06/2011
2	LigandsIBA 01/2017 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 01/2008
2	ProdrugsIBA 08/2014 - 06/2011
1	Adenosine Triphosphate (ATP)IBA 04/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Coloring Agents (Dyes)IBA 01/2021
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Serum AlbuminIBA 01/2021
1	CalpainIBA 01/2017
1	4- amino- 6- bromo- 1- (3,4- dihydroxy- 5- (hydroxymethyl)tetrahydrofuran- 2- yl)- 1H- pyrrolo(2,3- d)pyrimidine- 5- carboxamideIBA 06/2011
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 06/2011

Therapy/Procedure

1	Radiotherapy 08/2014
1	Chemoradiotherapy 08/2014